Innovating Works

BLOODGENETICS

Activa
ADGENTHE-CDA: Advances in the Diagnosis and Gene Therapy of Congenital dyserythropoietic Anemia BLOODGENETICS tramitó un H2020: H2020-MSCA-IF-2019 The emergence of next-generation sequencing technology (NGS) has revolutionized the diagnosis of genetic diseases including hereditary haema...
2020-03-16 - 2023-03-15 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.